Financial release accessible
online
BOSTON, Aug. 8, 2023
/PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that
financial results for its first quarter fiscal 2024, which ended
July 1, 2023, are available on its
Investor Relations website.
The Company will host a conference call and webcast with
investors and analysts to discuss and answer questions about the
results at 8:00 a.m. ET on
August 8, 2023. The conference call
and webcast can be accessed with the following information:
- Teleconference link:
https://register.vevent.com/register/BI161cbc44c95c40ac857474a72c5ba4c0
- Once registration is completed, participants will receive a
dial-in number along with a personalized PIN to access the call.
While not required, it is recommended that participants join 10
minutes prior to the event start.
- A live webcast of the call can be accessed on Haemonetics'
investor relations website or via the following link:
https://edge.media-server.com/mmc/p/y8b7kg5q
In addition, the Company has posted to its Investor Relations
website the earnings release that will be referenced on its
conference call and webcast, a link to which is available
below.
Direct link to 1Q FY24 Earnings Release:
https://haemonetics.gcs-web.com/static-files/59d8e57d-0800-42fb-9047-72f4fac27a89
A replay of the conference call and webcast will be available
for one year beginning on August 8,
2023, at 11:00 a.m. ET using
the conference call webcast link provided in this press
release.
About Haemonetics
Haemonetics (NYSE: HAE) is a global
healthcare company dedicated to providing a suite of innovative
medical products and solutions for customers, to help them improve
patient care and reduce the cost of healthcare. Our technology
addresses important medical markets: blood and plasma component
collection, the surgical suite and hospital transfusion services.
To learn more about Haemonetics, visit www.haemonetics.com.
|
Investor
Contacts:
|
|
|
Olga Guyette, Sr.
Director-Investor Relations & Treasury
|
David Trenk,
Manager-Investor Relations
|
|
(781) 356-9763
|
(203)
733-4987
|
|
olga.guyette@haemonetics.com
|
david.trenk@haemonetics.com
|
|
|
|
Media
Contact:
|
|
|
Josh Gitelson,
Director-Global Communications
|
|
|
(781)
356-9776
|
|
|
josh.gitelson@haemonetics.com
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/haemonetics-1st-quarter-fiscal-year-2024-earnings-release-available-on-investor-relations-website-301895394.html
SOURCE Haemonetics Corporation